Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview of Australia's state-wide cardiovascular program and reflections on its piloting between 2021 and 2024.

Health policy (Amsterdam, Netherlands)·2025
Same author

Magnetotelluric support for edge-driven convection and shear-driven upwelling in the Newer Volcanics Province.

Scientific reports·2023
Same author

Perceptions of friendship, peers and influence on adolescent smoking according to tobacco control context: a systematic review and meta-ethnography of qualitative research.

BMC public health·2023
Same author

Validation of the 8-item Centre for Epidemiological Studies Depression Scale in a cohort of community-dwelling older people: data from The Irish Longitudinal Study on Ageing (TILDA).

European geriatric medicine·2021
Same author

Verbal intelligence is a more robust cross-sectional measure of cognitive reserve than level of education in healthy older adults.

Alzheimer's research & therapy·2021
Same author

Systematic Review and Meta: Analysis of Aortic Graft Infections following Abdominal Aortic Aneurysm Repair.

International journal of vascular medicine·2020

Related Experiment Videos

Structuring diabetes care in general practices: many improvements, remaining challenges.

S Jennings1, D L Whitford, D Carey

  • 1Dept of Public Health Medicine, Health Service Executive, Dr Steevens Hospital, Dublin. siobhan.jennings@mailf.hse.ie

Irish Journal of Medical Science
|February 23, 2007
PubMed
Summary

Structured diabetes care in general practice improved patient outcomes and vascular risk. This systematic approach enhances longevity and quality of life for individuals with type 2 diabetes.

Related Experiment Videos

Area of Science:

  • Diabetes management
  • General practice
  • Public health

Background:

  • Systematic organization of care is crucial for improving longevity and quality of life in individuals with type 2 diabetes.
  • Current care models may not fully meet the needs of patients with type 2 diabetes.

Purpose of the Study:

  • To evaluate the impact of transitioning to structured diabetes care within a general practice setting, shared with secondary care.
  • To assess changes in care processes and intermediate outcomes for type 2 diabetes patients.

Main Methods:

  • A comparative audit was conducted in 10 Dublin general practices.
  • Data on process and intermediate outcomes were collected before and after the implementation of structured care.
  • The audit covered a four-year period following the care model change.

Main Results:

  • Structured diabetes care led to the establishment of dedicated clinics and improved care processes.
  • Access to multidisciplinary expertise increased significantly.
  • Key improvements observed include better blood pressure control, increased use of aspirin, and higher rates of lipid-lowering agent prescription.
  • These improvements suggest a significant reduction in the absolute risk of vascular events.

Conclusions:

  • Structured care models in general practice demonstrably improve intermediate outcomes for type 2 diabetes patients.
  • While improvements were noted, further enhancements are necessary to align with international treatment targets.
  • The findings support the integration of structured diabetes care within primary care settings.